Commentary on “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial” by Gautret et al

por Toumi, Mondher, Aballea, Samuel
Publicado 2020

A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting β(2)-agonists for asthma maintenance tr...

por Aballéa, S, Cure, S, Vogelmeier, C, Wirén, A
Publicado 2008

An Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static Model

por Chit, Ayman, Roiz, Julie, Aballea, Samuel
Publicado 2015

Measuring the health-related quality of life in young children: how far have we come?

por Germain, Nicola, Aballéa, Samuel, Toumi, Mondher
Publicado 2019

Factors influencing the COVID-19 daily deaths' peak across European countries

por Jabłońska, Katarzyna, Aballéa, Samuel, Toumi, Mondher
Publicado 2021

The real-life impact of vaccination on COVID-19 mortality in Europe and Israel

por Jabłońska, Katarzyna, Aballéa, Samuel, Toumi, Mondher
Publicado 2021

On the association between SARS-COV-2 variants and COVID-19 mortality during the second wave of the pandemic in Europe

por Jabłońska, Katarzyna, Aballéa, Samuel, Auquier, Pascal, Toumi, Mondher
Publicado 2021

Systematic review of utility values used in the pharmacoeconomic evaluations for schizophrenia: implications on cost-effectiveness results

por Zhou, Junwen, Millier, Aurélie, François, Clément, Aballéa, Samuel, Toumi, Mondher
Publicado 2019

Analysis of health-related quality of life and costs based on a randomised clinical trial of escitalopram for relapse prevention in patients with generalised social anxiety disorde...

por François, C, Montgomery, S A, Despiegel, N, Aballéa, S, Roïz, J, Auquier, P
Publicado 2008

Ischemic stroke management in West Scotland: a chart review

por Verpillat, Patrice, Dorey, Julie, Guilhaume-Goulant, Chantal, Dabbous, Firas, Aballéa, Samuel
Publicado 2015

Quality of life is predictive of relapse in schizophrenia

por Boyer, Laurent, Millier, Aurelie, Perthame, Emeline, Aballea, Samuel, Auquier, Pascal, Toumi, Mondher
Publicado 2013

Impact of therapy escalation on ambulatory care costs among patients with type 2 diabetes in France

por Guelfucci, Florent, Clay, Emilie, Aballéa, Samuel, Lassalle, Régis, Moore, Nicholas, Toumi, Mondher
Publicado 2013

Estimating EQ-5D and OAB-5D health state utilities for patients with overactive bladder

por Desroziers, Katia, Aballéa, Samuel, Maman, Khaled, Nazir, Jameel, Odeyemi, Isaac, Hakimi, Zalmai
Publicado 2013

A comparison of HAS & NICE guidelines for the economic evaluation of health technologies in the context of their respective national health care systems and cultural environments

por Massetti, Marc, Aballéa, Samuel, Videau, Yann, Rémuzat, Cécile, Roïz, Julie, Toumi, Mondher
Publicado 2015

Use of Patient Preference Information in Benefit–Risk Assessment, Health Technology Assessment, and Pricing and Reimbursement Decisions: A Systematic Literature Review of Attempts...

por Chachoua, Lylia, Dabbous, Monique, François, Clément, Dussart, Claude, Aballéa, Samuel, Toumi, Mondher
Publicado 2020

Allocating treatment resources for hepatitis C in the UK: a constrained optimization modelling approach

por Han, Ru, Liang, Shuyao, François, Clément, Aballea, Samuel, Clay, Emilie, Toumi, Mondher
Publicado 2021

Efficacy of rFIXFc versus rIX-FP for the Treatment of Patients with Hemophilia B: Matching-Adjusted Indirect Comparison of B-LONG and PROLONG-9FP Trials

por Astermark, Jan, Wojciechowski, Piotr, Aballéa, Samuel, Hakimi, Zalmai, Nazir, Jameel, Klamroth, Robert
Publicado 2021

A chart review of management of ischemic stroke patients in Germany

por Verpillat, Patrice, Dorey, Julie, Guilhaume-Goulant, Chantal, Dabbous, Firas, Brunet, Julie, Aballéa, Samuel
Publicado 2015

Determinants of orphan drugs prices in France: a regression analysis

por Korchagina, Daria, Millier, Aurelie, Vataire, Anne-Lise, Aballea, Samuel, Falissard, Bruno, Toumi, Mondher
Publicado 2017

Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies

por Pochopien, Michal, Beiderbeck, Annette, McEwan, Phil, Zur, Richard, Toumi, Mondher, Aballéa, Samuel
Publicado 2019